南斯拉夫血栓形成倾向患者中凝血因子V莱顿突变的患病率及其与活化蛋白C抵抗实验室诊断的关系。 - Suppr

Suppr

超能文献

Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance.

作者信息

Mikovic D, Rakicevic L, Kovac M, Radojkovic D

出版信息

Thromb Haemost. 2000 Oct;84(4):723-4.

PMID:11057877

Abstract

摘要

相似文献

Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance.南斯拉夫血栓形成倾向患者中凝血因子V莱顿突变的患病率及其与活化蛋白C抵抗实验室诊断的关系。

Thromb Haemost. 2000 Oct;84(4):723-4.

Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.真性红细胞增多症和原发性血小板增多症中因子V莱顿突变携带者与静脉血栓栓塞症

Am J Hematol. 2002 Sep;71(1):1-6. doi: 10.1002/ajh.10153.

The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and Arteriosclerosis.VITA项目：对活化蛋白C抵抗的遗传性。文森扎血栓形成倾向与动脉硬化。

Thromb Haemost. 2000 Nov;84(5):811-4.

Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.在欧洲和美国的两个中心对一种用于检测活化蛋白C抵抗（Pefakit APC-R因子V莱顿）的新功能测试进行临床评估。

Thromb Res. 2007;119(1):17-26. doi: 10.1016/j.thromres.2006.06.015. Epub 2006 Aug 23.

[APC resistance--most frequent familial thrombophilia].[抗磷脂酶C抵抗——最常见的家族性易栓症]

Ther Umsch. 1999 Sep;56(9):499-501. doi: 10.1024/0040-5930.56.9.499.

[National evaluation of the diagnosis of activated protein C resistance].[活化蛋白C抵抗诊断的全国性评估]

Rev Invest Clin. 2003 May-Jun;55(3):358-69.

In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivity.

Thromb Haemost. 2000 Jun;83(6):963-4.

Activated protein C (APC) resistance: considerations about the importance of using the original and modified methods in thrombophilic disease.活化蛋白C（APC）抵抗：关于在血栓形成倾向疾病中使用原始方法和改良方法的重要性的思考。

Thromb Haemost. 2000 Jul;84(1):138-9.

Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.原发性上肢深静脉血栓形成：血栓形成倾向缺陷的高患病率。

Am J Hematol. 2004 Aug;76(4):330-7. doi: 10.1002/ajh.20131.

Screening with the activated protein C resistance assay yields significant savings in a patient population with low prevalence of factor V leiden.对于因子V莱顿突变低患病率的患者群体，采用活化蛋白C抵抗试验进行筛查可显著节省费用。

Am J Clin Pathol. 2008 Mar;129(3):494-9. doi: 10.1309/4370VLY9PBDDEWF6.

引用本文的文献

Prevalence of 1691G>A FV mutation in Poland compared with that in other Central, Eastern and South-Eastern European countries.波兰 1691G>A FV 突变的流行率与其他中东欧和东南欧国家的流行率相比。

Bosn J Basic Med Sci. 2012 May;12(2):82-7. doi: 10.17305/bjbms.2012.2500.

Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.地中海地区活化蛋白 C 抵抗和因子 V 莱顿突变的流行病学。

Mediterr J Hematol Infect Dis. 2011;3(1):e2011037. doi: 10.4084/MJHID.2011.037. Epub 2011 Sep 8.

The role of ethnicity, age and gender in venous thromboembolism.种族、年龄和性别在静脉血栓栓塞中的作用。

J Thromb Thrombolysis. 2010 May;29(4):489-96. doi: 10.1007/s11239-009-0365-8.

FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.塞尔维亚人群中的FV莱顿突变与复发性静脉血栓栓塞风险

J Thromb Thrombolysis. 2008 Jun;25(3):284-7. doi: 10.1007/s11239-007-0059-z. Epub 2007 Jun 5.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验